Literature DB >> 25868635

Outcomes After Anterior Cruciate Ligament Reconstruction Using the Norwegian Knee Ligament Registry of 4691 Patients: How Does Meniscal Repair or Resection Affect Short-term Outcomes?

Christopher M LaPrade1, Grant J Dornan2, Lars-Petter Granan3, Robert F LaPrade4, Lars Engebretsen5.   

Abstract

BACKGROUND: While the effects of concurrent meniscal resection and anterior cruciate ligament reconstruction (ACLR) are known to decrease patient outcomes and increase the rate of osteoarthritis over the long term, overall short-term patient functional outcomes in a large cohort of patients are not well known. PURPOSE/HYPOTHESIS: The purpose of this study was to compare the preoperative and 2-year postoperative Knee Injury and Osteoarthritis Outcome Score (KOOS) subscale scores after ACLR with and without meniscal injury. The hypothesis was that, in comparison with an isolated ACLR, patients with a medial meniscal (MM) or lateral meniscal (LM) resection with an ACLR would have significantly decreased 2-year postoperative KOOS outcomes, while those with an ACLR with an MM or LM repair would be indistinguishable from isolated ACLR. STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: The Norwegian Knee Ligament Registry (NKLR) was used to evaluate outcomes for a total of 4691 patients with primary ACLR. The KOOS scoring system was used to evaluate patients on 5 subscales (Pain, Other Symptoms, Activities of Daily Life [ADL], Sport and Recreation Function, and Quality of Life [QoL]) at time of surgery and at 2-year postoperative follow-up. Patients with isolated ACLR and ACLR with LM repair, LM resection, MM repair, or MM resection were compared using multiple linear regression modeling.
RESULTS: Preoperatively, in comparison with isolated ACLR, patients who had an ACLR with either an MM repair or MM resection had significantly lower scores for all KOOS subscores, and LM repair had significantly decreased scores on the Other Symptoms, Pain, and ADL subscales. Postoperatively, in comparison with isolated ACLR, 2-year KOOS outcomes were not significantly different between patients with ACLR and LM repair, MM resection, or LM resection; however, those with MM repair had significantly lower scores on the Other Symptoms and QoL subscales.
CONCLUSION: Patients with ACLR with meniscal resections do not exhibit decreased clinical outcomes at 2 years postoperatively. It is recommended that clinicians follow patients with ACLR and concurrent meniscal treatment for longer than 2 years postoperatively.
© 2015 The Author(s).

Entities:  

Keywords:  anterior cruciate ligament; meniscal repair; meniscal resection; patient outcomes; registry

Mesh:

Year:  2015        PMID: 25868635     DOI: 10.1177/0363546515577364

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  27 in total

1.  Concomitant meniscal injury in anterior cruciate ligament reconstruction does not lead to poorer short-term post-operative outcomes.

Authors:  Amritpal Singh; Desmond Thiam Wei; Cheryl Tan Pei Lin; Shen Liang; Saumitra Goyal; Kimberly-Anne Tan; Brian Zhaojie Chin; Lingaraj Krishna
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-07-15       Impact factor: 4.342

2.  Medial meniscal and chondral pathology at the time of revision anterior cruciate ligament reconstruction results in inferior mid-term patient-reported outcomes.

Authors:  Kate E Webster; Julian A Feller; Alexander Kimp; Brian M Devitt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-07       Impact factor: 4.342

3.  Hospital for Special Surgery ACL Registry: 2-Year Outcomes Suggest Low Revision and Return to OR Rates.

Authors:  Moira McCarthy; Katherine Mallett; Matthew Abola; Sherrie Vassallo; Joseph Nguyen
Journal:  HSS J       Date:  2016-11-22

4.  Clinical measures associated with knee function over two years in young athletes after ACL reconstruction.

Authors:  Matthew P Ithurburn; Mark V Paterno; Staci Thomas; Michael L Pennell; Kevin D Evans; Robert A Magnussen; Laura C Schmitt
Journal:  Knee       Date:  2019-02-14       Impact factor: 2.199

5.  Meniscus repair with simultaneous ACL reconstruction demonstrated similar clinical outcomes as isolated ACL repair: a result not seen with meniscus resection.

Authors:  Mark Phillips; Erik Rönnblad; Love Lopez-Rengstig; Eleonor Svantesson; Anders Stålman; Kalle Eriksson; Olufemi R Ayeni; Kristian Samuelsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-02-28       Impact factor: 4.342

6.  Incidence and type of meniscal tears in multilligament injured knees.

Authors:  Chloé Labarre; Seong Hwan Kim; Nicolas Pujol
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-07-19       Impact factor: 4.114

7.  Meniscal repair at the time of primary ACLR does not negatively influence short term knee stability, graft rupture rates, or patient-reported outcome measures: the STABILITY experience.

Authors:  Hana Marmura; Andrew Firth; Lachlan Batty; Dianne M Bryant; Alan M J Getgood
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-04-22       Impact factor: 4.114

Review 8.  Clinical and radiographic outcomes of meniscus surgery and future targets for biologic intervention: A review of data from the MOON Group.

Authors:  Robert W Westermann; Morgan Jones; David Wasserstein; Kurt P Spindler
Journal:  Connect Tissue Res       Date:  2017-03-10       Impact factor: 3.417

9.  Does meniscal pathology alter gait knee biomechanics and strength post-ACL reconstruction?

Authors:  Michelle Hall; Adam L Bryant; Tim V Wrigley; Clare Pratt; Kay M Crossley; Tim S Whitehead; Hayden G Morris; Ross A Clark; Luke G Perraton
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-14       Impact factor: 4.342

10.  Do Knee Bracing and Delayed Weight Bearing Affect Mid-Term Functional Outcome after Anterior Cruciate Ligament Reconstruction?

Authors:  Riccardo Di Miceli; Carlotta Bustos Marambio; Alessandro Zati; Roberta Monesi; Maria Grazia Benedetti
Journal:  Joints       Date:  2017-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.